Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/531207 stock hub

BOM/531207 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/531207is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

19.9M

Bombay Stock Exchange

Market data

Price

Recent price action with selectable time range.

BOM/531207BOM/531207

—

Loading chart…

In the news

Latest news · BOM/531207

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC6.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/531207 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

138

Groups with data

Currency

INR

Showing 138 of 138 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	5
Employees Change	3%
Employees Change Percent	150
Enterprise value	INR 44.5M
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 19.9M
Price	INR 4.65
Price currency	INR
Rev Per Employee	1,182,400x
Sic	2834
Symbol	bom/531207
Website	https://www.raymedlab.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.63%
EV Earnings	-48.32x
EV/EBIT	194.33x
EV/EBITDA	169.85x
EV/Sales	7.53x
P/B ratio	-0.74x
P/S ratio	3.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.87%
EBITDA Margin	4.43%
Gross margin	91.17%
Gross Profit	INR 5.4M
Gross Profit Growth	6,167.44%
Gross Profit Growth Q	132.56%
Net Income	INR -921,000
Pretax Margin	-15.58%
Profit Margin	-15.58%
Profit Per Employee	INR -184,200
Roa5y	-35.44
ROIC	6.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.04%
Cagr1y	46.73%
Cagr3y	31.6%
Cagr5y	37.68%
Revenue Growth	6,774.42x
Revenue Growth Q	132.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 83,000
Debt	INR 24.7M
Debt EBITDA	INR 94.32
Equity	INR -26.9M
Interest Coverage	0.2
Net Cash	INR -24.6M
Net Cash By Market Cap	INR -124
Net Debt EBITDA	INR 94.01
Tangible Book Value	INR -26.9M
Tangible Book Value Per Share	INR -6.33
WACC	3.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	25.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	48.56%
1Y total return	46.69%
200-day SMA	2.01
3Y total return	127.94%
50-day SMA	2.87
50-day SMA vs 200-day SMA	50over200
5Y total return	394.68%
All Time High	46.9
All Time High Change	-90.09%
All Time High Date	2011-07-19
All Time Low	0.92
All Time Low Change	405.43%
All Time Low Date	2021-06-07
ATR	0.1
Beta	0.01
Beta1y	-0.03
Beta2y	0.01
Ch YTD	21.41
High	4.65
High52	4.65
High52 Date	2026-04-20
High52ch	0%
Low	4.65
Low52	3.32
Low52 Date	2025-05-12
Low52ch	40.06%
Ma50ch	61.96%
Price vs 200-day SMA	131.11%
RSI	97.48
RSI Monthly	90.72
RSI Weekly	68.46
Sharpe ratio	0.94x
Sortino ratio	1.52
Total Return	25.37%
Tr YTD	21.41
Tr1m	4.97%
Tr3m	15.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 229,000
Operating Income Growth5 Y	29.62
Operating margin	3.87

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,938,930%
Shares Insiders	40.47%
Shares Institutions	1.18%
Shares Out	4,273,500
Shares Qo Q	0.96%
Shares Yo Y	-25.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,797.7x
Bv Per Share	-6.33
Ch10y	48.56
Ch1m	4.97
Ch1y	46.69
Ch3m	15.67
Ch3y	127.9
Ch5y	394.7
Ch6m	27.4
Change	4.97%
Change From Open	0
Close	4.43
Days Gap	4.97
Depreciation Amortization	33,000
Dollar Volume	930
Earnings Date	2026-05-22
EBIT	INR 229,000
EBITDA	INR 262,000
EPS	INR -0.22
F Score	0
Fiscal Year End	March
Founded	1,992
Is Primary Listing	1
Last Earnings Date	2026-02-04
Last Report Date	2025-12-31
Ma150	1.93
Ma150ch	141.18%
Ma20	3.56
Ma20ch	30.76%
Next Earnings Date	2026-05-22
Open	4.65
Price Date	2026-04-20
Price EBITDA	INR 75.85
Relative Volume	0.11x
Revenue	5,912,000x
Tr6m	27.4%
Volume	200

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/531207 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/531207 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/531207?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.2%

Share of float held by funds and institutions

Insider ownership

+40.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-25.4%

Negative means the company is buying back shares.

Technical

BOM/531207 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

97.5

Above 70: short-term overbought

Price vs 200-day MA

+131.1%

50/200-day relationship not available

Beta (5Y)

0.01

Less volatile than the market

Sharpe ratio

0.94

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/531207

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/531207 stock rating?

bom/531207 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/531207 analysis?

The full report lives at /stocks/bom/531207/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/531207?

The latest report frames bom/531207 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/531207 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.